Bioactivity:

TAK-259 is a novel, selective, and orally active _1D adrenergic receptor antagonist (_1D, Ki = 1.1 nM) that represents a promising new therapeutic agent for the treatment of symptoms of OAB. It has an anti-frequency effect and reduces the burden of the hu

CAS nr:

1192347-42-4

Purity:

98%

Molecular Weight:

410,69

SMILES:

O=C(C1=CC(Cl)=CN(CC2=CC(Cl)=CC=C2S(=O)(C)=O)C1=N)N.[H]Cl

Formula:

C14H14Cl3N3O3S

Pathway:

Target: